GRFSGrifois, S.A.

ADRCNasdaq (XNAS)·USD

Identity

Security key: 16218
Ticker: GRFS
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2011-06-02
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GRFS

Detail

Enriched 2026-08-14 20:47

Market cap: $5,397,003,420.51
Shares outstanding (class): 261,425,110
Shares outstanding (weighted): 680,580,507
SIC: —
Employees: 25,247
Location: —
Homepage: https://www.grifols.com
Description: Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Market cap and share counts drift.

Funds holding this security

15 funds · 15 positions · $237.66M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
New Perspective Fund New Perspective Fund	—	$112.59M	0.07%	14,039,027 NS	FIGI
International Growth and Income Fund International Growth & Income Fund	—	$41.55M	0.22%	5,180,416 NS	FIGI
Brandes International Small Cap Equity Fund Datum One Series Trust	—	$37.45M	2.57%	4,669,548 NS	FIGI
Oakmark International Small Cap Fund HARRIS ASSOCIATES INVESTMENT TRUST	—	$11.17M	0.96%	1,392,400 NS	FIGI
Brandes Small Cap Value Fund Datum One Series Trust	—	$10.57M	2.29%	1,318,045 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$7.83M	0.10%	976,161 NS	FIGI
Brandes International ETF The 2023 ETF Series Trust	BINV	$6.90M	1.50%	859,739 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.74M	0.12%	341,628 NS	FIGI
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$2.43M	0.01%	303,379 NS	FIGI
Brandes U.S. Small-Mid Cap Value ETF The 2023 ETF Series Trust	BSMC	$2.12M	1.37%	263,731 NS	FIGI
International Growth and Income Fund AMERICAN FUNDS INSURANCE SERIES	—	$897.2K	0.21%	111,869 NS	FIGI
Brandes Global Equity Fund Datum One Series Trust	—	$781.6K	0.93%	97,452 NS	FIGI
Quantified Global Fund Advisors Preferred Trust	—	$396.9K	1.43%	49,495 NS	FIGI
1290 VT GAMCO Mergers & Acquisitions Portfolio EQ Advisors Trust	—	$192.5K	0.11%	24,000 NS	FIGI
Enterprise Mergers and Acquisitions Fund Gabelli 787 Fund, Inc.	—	$56.1K	0.10%	7,000 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGRFS
FIGI_COMPOSITEBBG001QMCKF6
FIGI_SHARE_CLASSBBG001V1HXJ9
CIK0001438569
ISINUS3984384087
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Grifols is a pharmaceutical company specializing in plasma-derived therapies.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.